19th Nov 2020 11:51
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 18 November 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
3,011,485 | 2.34% | 691,372 | 0.54% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
366,635 | 0.28% | 739,005 | 0.57% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
3,378,120 | 2.62% | 1,430,377 | 1.11% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 208.3100 USD |
Purchase | 4 | 210.8900 USD |
Purchase | 8 | 208.0650 USD |
Purchase | 14 | 207.3671 USD |
Purchase | 46 | 210.6900 USD |
Purchase | 77 | 210.6800 USD |
Purchase | 100 | 210.0850 USD |
Purchase | 100 | 207.7500 USD |
Purchase | 117 | 210.4142 USD |
Purchase | 136 | 206.5687 USD |
Purchase | 146 | 206.8490 USD |
Purchase | 157 | 210.5962 USD |
Purchase | 186 | 208.3166 USD |
Purchase | 229 | 209.6001 USD |
Purchase | 274 | 210.6870 USD |
Purchase | 276 | 209.6191 USD |
Purchase | 300 | 210.0467 USD |
Purchase | 400 | 205.9667 USD |
Purchase | 407 | 209.1210 USD |
Purchase | 1,194 | 207.6606 USD |
Purchase | 1,420 | 208.2116 USD |
Purchase | 2,090 | 207.5127 USD |
Purchase | 2,709 | 207.3197 USD |
Purchase | 3,364 | 207.9857 USD |
Purchase | 3,848 | 206.8600 USD |
Purchase | 4,668 | 208.2003 USD |
Purchase | 7,550 | 207.7610 USD |
Purchase | 8,431 | 207.8328 USD |
Purchase | 9,415 | 205.7000 USD |
Purchase | 10,591 | 207.8386 USD |
Purchase | 37,288 | 206.1116 USD |
Sale | 1 | 210.7300 USD |
Sale | 2 | 211.0950 USD |
Sale | 3 | 210.3433 USD |
Sale | 4 | 210.3400 USD |
Sale | 4 | 209.6025 USD |
Sale | 4 | 210.0912 USD |
Sale | 7 | 210.2850 USD |
Sale | 7 | 210.0500 USD |
Sale | 8 | 209.4943 USD |
Sale | 11 | 209.3081 USD |
Sale | 15 | 209.3026 USD |
Sale | 15 | 206.0200 USD |
Sale | 35 | 208.1837 USD |
Sale | 59 | 207.6200 USD |
Sale | 70 | 209.7957 USD |
Sale | 73 | 206.8490 USD |
Sale | 82 | 209.8280 USD |
Sale | 99 | 209.1476 USD |
Sale | 100 | 207.7500 USD |
Sale | 100 | 209.1790 USD |
Sale | 115 | 209.0039 USD |
Sale | 122 | 206.3875 USD |
Sale | 123 | 208.7829 USD |
Sale | 176 | 207.0078 USD |
Sale | 189 | 209.0449 USD |
Sale | 255 | 208.9831 USD |
Sale | 277 | 210.6800 USD |
Sale | 342 | 210.6794 USD |
Sale | 1,824 | 208.3864 USD |
Sale | 2,156 | 205.9428 USD |
Sale | 2,617 | 205.9504 USD |
Sale | 2,724 | 207.4052 USD |
Sale | 5,866 | 210.1466 USD |
Sale | 6,607 | 207.6800 USD |
Sale | 7,403 | 205.7000 USD |
Sale | 15,017 | 206.1089 USD |
Sale | 22,903 | 206.1379 USD |
Sale | 25,994 | 207.4360 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 19 Nov 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20201119005658/en/
Copyright Business Wire 2020
Related Shares:
Barclays